Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale

Journal of Immunology

Volumn 174, Issue 11, 2005, Pages 6702-6715

  Abbott, Jeffrey R ^a   Palmer, Guy H ^a   Kegerreis, Kimberly A ^a   Hetrick, Peter F ^a   Howard, Chris J ^b   Hope, Jayne C ^b   Brown, Wendy C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM VACCINE; CYTOKINE; EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; MAJOR SURFACE PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANAPLASMA MARGINALE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENIC VARIATION; ARTICLE; BOVIDS; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNE RESPONSE; INFECTION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PRIORITY JOURNAL; RICKETTSIOSIS; T LYMPHOCYTE;

EID: 18944375014     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.11.6702     Document Type: Article

References (61)

1. Zhi, N., N. Ohashi, Y. Rikihisa, H. W. Horowitz, G. P. Wormser, and K. Hechemy. 1998. Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J. Clin. Microbiol. 36: 1666-1673.
2. Shkap, V., T. Molad, K. A. Brayton, W. C. Brown, and G. H. Palmer. 2002. Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates. Infect. Immun. 70: 642-648.
3. Palmer, G. H., J. R. Abbott, D. M. French, and T. F. McElwain. 1998. Persistence of Anaplasma ovis infection and conservation of the msp-2 and msp-3 multigene families within the genus Anaplasma. Infect. Immun. 66: 6035-6039.
4. Murphy, C. I., J. R. Storey, J. Recchia, L. A. Doros-Richert, C. Gingrich-Baker, K. Munroe, J. S. Bakken, R. T. Coughlin, and G. A. Beltz. 1998. Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family. Infect. Immun. 66: 3711-3718.
5. Ijdo, J. W., W. Sun, Y. Zhang, L. A. Magnarelli, and E. Fikrig. 1998. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect. Immun. 66: 3264-3269.
6. French, D. M., T. F. McElwain, T. C. McGuire, and G. H. Palmer. 1998. Expression of Anaplasma marginale major surface protein 2 variants during persistent cyclic rickettsemia. Infect. Immun. 66: 1200-1207.
7. French, D. M., W. C. Brown, and G. H. Palmer. 1999. Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia. Infect. Immun. 67: 5834-5840.
8. Brayton, K. A., P. F. Meeus, A. F. Barbet, and G. H. Palmer. 2003. Simultaneous variation of the immunodominant outer membrane proteins, MSP2 and MSP3, during Anaplasma marginale persistence in vivo. Infect. Immun. 71: 6627-6632.
9. Brayton, K. A., G. H. Palmer, A. Lundgren, J. Yi, and A. F. Barbet. 2002. Antigenic variation of Anaplasma marginale msp2 occurs by combinatorial gene conversion. Mol. Microbiol. 43: 1151-1159.
10. + T lymphocyte epitopes that elicit variant-specific proliferative and IFN-γ responses in MSP2 vaccinates. J. Immunol. 170: 3790-3798.
11. + T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3. Infect. Immun. 72: 3688-3692.
12. Barbet, A. F., A. Lundgren, J. Yi, F. R. Rurangirwa, and G. H. Palmer. 2000. Antigenic variation of Anaplasma marginale by expression of MSP2 mosaics. Infect. Immun. 68: 6133-6138.
13. Barbet, A. F., P. F. Meeus, M. Belanger, M. V. Bowie, J. Yi, A. M. Lundgren, A. R. Alleman, S. J. Wong, F. K. Chu, U. G. Munderloh, and S. D. Jauron. 2003. Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect. Immun. 71: 1706-1718.
14. Palmer, G. H., W. C. Brown, and F. R. Rurangirwa. 2000. Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginale. Microbes Infect. 2: 167-176.
15. Palmer, G. H., G. Eid, A. F. Barbet, T. C. McGuire, and T. F. McElwain. 1994. The immunoprotective Anaplasma marginale major surface protein 2 is encoded by a polymorphic multigene family. Infect. Immun. 62: 3808-3816.
16. Palmer, G. H., and T. F. McElwain. 1995. Molecular basis for vaccine development against anaplasmosis and babesiosis. Vet. Parasitol. 57: 233-253.
17. Palmer, G. H., D. Munodzana, N. Tebele, T. Ushe, and T. F. McElwain. 1994. Heterologous strain challenge of cattle immunized with Anaplasma marginale outer membranes. Vet. Immunol. Immunopathol. 42: 265-273.
18. Palmer, G. H., S. M. Oberle, A. F. Barbet, W. L. Goff, W. C. Davis, and T. C. McGuire. 1988. Immunization of cattle with a 36-kilodalton surface protein induces protection against homologous and heterologous Anaplasma marginale challenge. Infect. Immun. 56: 1526-1531.
19. Palmer, G. H., F. R. Rurangirwa, K. M. Kocan, and W. C. Brown. 1999. Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale. Parasitol. Today 15: 281-286.
20. Wang, X., Y. Rikihisa, T. H. Lai, Y. Kumagai, N. Zhi, and S. M. Reed. 2004. Rapid sequential changeover of expressed p44 genes during the acute phase of Anaplasma phagocytophilum infection in horses. Infect. Immun. 72: 6852-6859.
21. Eriks, I. S., D. Stiller, and G. H. Palmer. 1993. Impact of persistent Anaplasma marginale rickettsemia on tick infection and transmission. J. Clin. Microbiol. 31: 2091-2096.
22. Eriks, I. S., G. H. Palmer, T. C. McGuire, D. R. Allred, and A. F. Barbet. 1989. Detection and quantitation of Anaplasma marginale in carrier cattle by using a nucleic acid probe. J. Clin. Microbiol. 27: 279-284.
23. Kieser, S. T., I. S. Eriks, and G. H. Palmer. 1990. Cyclic rickettsemia during persistent Anaplasma marginale infection of cattle. Infect. Immun. 58: 1117-1119.
24. Meeus, P. F., K. A. Brayton, G. H. Palmer, and A. F. Barbet. 2003. Conservation of a gene conversion mechanism in two distantly related paralogues of Anaplasma marginale. Mol. Microbiol. 47: 633-643.
25. + T-cell epitopes are evenly distributed in conserved and hypervariable regions (HVR), whereas linear B-cell epitopes are predominantly located in the HVR. Infect. Immun. 72: 7360-7366.
26. + T lymphocyte epitopes that elicit strong recall responses. J. Immunol. 166: 1114-1124.
27. Torioni de Echaide, S., D. P. Knowles, T. C. McGuire, G. H. Palmer, C. E. Suarez, and T. F. McElwain. 1998. Detection of cattle naturally infected with Anaplasma marginale in a region of endemicity by nested PCR and a competitive enzyme-linked immunosorbent assay using recombinant major surface protein 5. J. Clin. Microbiol. 36: 777-782.
28. Zhang, Y., G. H. Palmer, J. R. Abbott, C. J. Howard, J. C. Hope, and W. C. Brown. 2003. CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum. Vaccine 21: 3307-3318.
29. Palmer, G. H., and T. C. McGuire. 1984. Immune serum against Anaplasma marginale initial bodies neutralizes infectivity for cattle. J. Immunol. 133: 1010-1015.
30. Tuo, W., G. H. Palmer, T. C. McGuire, D. Zhu, and W. C. Brown. 2000. Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen Anaplasma marginale. Infect. Immun. 68: 270-280.
31. Oberle, S. M., G. H. Palmer, A. F. Barbet, and T. C. McGuire. 1988. Molecular size variations in an immunoprotective protein complex among isolates of Anaplasma marginale. Infect. Immun. 56: 1567-1573.
32. Shoda, L. K., D. S. Zarlenga, A. Hirano, and W. C. Brown. 1999. Cloning of a cDNA encoding bovine interleukin-18 and analysis of IL-18 expression in macrophages and its IFN-γ-inducing activity. J. Interferon Cytokine Res. 19: 1169-1177.
33. + T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. Infect. Immun. 66: 5406-5413.
34. Kwong, L. S., J. C. Hope, M. L. Thom, P. Sopp, S. Duggan, G. P. Bembridge, and C. J. Howard. 2002. Development of an ELISA for bovine IL-10. Vet. Immunol. Immunopathol. 85: 213-223.
35. + T cell immunodominant Anaplasma marginale major surface protein 2 stimulates γδ T cell clones that express unique T cell receptors. J. Leukocyte Biol. 77: 199-208.
36. Eid, G., D. M. French, A. M. Lundgren, A. F. Barbet, T. F. McElwain, and G. H. Palmer. 1996. Expression of major surface protein 2 antigenic variants during acute Anaplasma marginale rickettsemia. Infect. Immun. 64: 836-841.
37. McGuirk, P., and K. H. Mills. 2002. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 23: 450-455.
38. Levings, M. K., R. Bacchetta, U. Schulz, and M. G. Roncarolo. 2002. The role of IL-10 and TGF-β in the differentiation and effector function of T regulatory cells. Int. Arch. Allergy Immunol. 129: 263-276.
39. + regulatory T cell subsets. J. Leukocyte Biol. 74: 471-478.
40. Cobbold, S., and H. Waldmann. 1998. Infectious tolerance. Curr. Opin. Immunol. 10: 518-524.
41. Bielekova, B., and R. Martin. 2001. Antigen-specific immunomodulation via altered peptide ligands. J. Mol. Med. 79: 552-565.
42. Nishimura, Y., Y. Z. Chen, T. Kanai, H. Yokomizo, T. Matsuoka, and S. Matsushita. 1998. Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification. Intern. Med. 37: 804-817.
43. Plebanski, M., E. A. Lee, and A. V. Hill. 1997. Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein. Parasitology 115(Suppl.): S55-S66.
44. Khalifeh, M. S., and J. R. Stabel. 2004. Effects of γ-interferon, interleukin-10, and transforming growth factor-β on the survival of Mycobacterium avium subsp. paratuberculosis in monocyte-derived macrophages from naturally infected cattle. Infect. Immun. 72: 1974-1982.
45. Diterich, I., C. Rauter, C. J. Kirschning, and T. Hartung. 2003. Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect. Immun. 71: 3979-3987.
46. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
47. MacDonald, A. J., M. Duffy, M. T. Brady, S. McKiernan, W. Hall, J. Hegarty, M. Curry, and K. H. Mills. 2002. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185: 720-727.
48. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195: 221-231.
49. h2 shift. Int. Immunol. 12: 623-630.
50. Whist, S. K., A. K. Storset, G. M. Johansen, and H. J. Larsen. 2003. Modulation of leukocyte populations and immune responses in sheep experimentally infected with Anaplasma (formerly Ehrlichia) phagocytophilum. Vet. Immunol. Immunopathol. 94: 163-175.
51. Whist, S. K., A. K. Storset, and H. J. Larsen. 2002. Functions of neutrophils in sheep experimentally infected with Ehrlichia phagocytophila. Vet. Immunol. Immunopathol. 86: 183-193.
52. Poitout, F. M., J. K. Shinozaki, P. J. Stockwell, C. J. Holland, and S. K. Shukla. 2005. Genetic variants of Anaplasma phagocytophilum infecting dogs in western Washington State. J. Clin. Microbiol. 43: 796-801.
53. phox. J. Immunol. 164: 3946-3949.
54. Scaife, H., Z. Woldehiwet, C. A. Hart, and S. W. Edwards. 2003. Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo. Infect. Immun. 71: 1995-2001.
55. Choi, K. S., and J. S. Dumler. 2003. Early induction and late abrogation of respiratory burst in A. phagocytophilum-infected neutrophils. Ann. NY Acad. Sci. 990: 488-493.
56. Carlyon, J. A., D. Abdel-Latif, M. Pypaert, P. Lacy, and E. Fikrig. 2004. Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection. Infect. Immun. 72: 4772-4783.
57. Mott, J., Y. Rikihisa, and S. Tsunawaki. 2002. Effects of Anaplasma phagocytophila on NADPH oxidase components in human neutrophils and HL-60 cells. Infect. Immun. 70: 1359-1366.
58. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193: 70-81.
59. + T cell clones during primary HIV infection. Proc. Natl. Acad. Sci. USA 94: 9848-9853.
60. Hayashi, N., D. Liu, B. Min, S. Z. Ben-Sasson, and W. E. Paul. 2002. Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells. Proc. Natl. Acad. Sci. USA 99: 6187-6191.
61. Hope, J. C., L. S. Kwong, M. Thom, W. Mwangi, W. C. Brown, G. H. Palmer, S. Wattegedera, G. Entrican, and C. J. Howard. Development of detection methods for ruminant IL-4. J. Immunol. Methods In press.